Skip to main content
Publications
Goyal RK, Carter GC, Nagar SP, Smyth EN, Price GL, Huang Y-J, Bromund JL, Li L, Schilder JM, Davis KL, Kaye JA. Treatment patterns and resource utilization among patients with HR+/HER2– metastatic breast cancer in a privately insured US population. Poster presented at the 2016 San Antonio Breast Cancer Symposium; December 9, 2016. San Antonio, TX.
Goyal RK, Carter GC, Nagar SP, Smyth EN, Price GL, Huang Y-J, Bromund JL, Li L, Schilder JM, Davis KL, Kaye JA. Treatment patterns and resource utilization among elderly Medicare patients with HR+/HER2– metastatic breast cancer. Poster presented at the 2016 San Antonio Breast Cancer Symposium; December 9, 2016. San Antonio, TX.
Blonde L, Kitio-Dschassi B, Guerci B, Meyers J, Berria R, Ajmera M, Nikonova E, Davis K, Bertolini M, Raccah D. A real-world comparison of longitudinal HbA1c and health care costs in patients receiving two oral antidiabetic therapies, GLP-1RAs, or basal insulin. Presented at the 76th American Diabetes Association (ADA) Scientifc Sessions; June 13, 2016. New Orleans, LA.
Blonde L, Kitio-Dschassi B, Guerci B, Meyers J, Berria R, Ajmera M, Nikonova E, Davis K, Bertolini M, Raccah D. A real-world comparison of outcomes in patients receiving two oral antidiabetic therapies, GLP-1RAs, or basal insulin: an analysis of electronic medical record data. Poster presented at the 76th American Diabetes Association (ADA) Scientifc Sessions; June 12, 2016. New Orleans, LA.
Ajmera MR, Davis KL, Price G, Li L, Huang YJ, Price GL, Goyal RK, John WJ, Cuyun Carter G, Kaye JA, Boye ME. Economic outcomes associated with tumor histology among elderly patients with metastatic non–small cell lung cancer. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 24, 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A165.